先進性非小細胞肺がんにおける不確実な意味を持つNRG1変異体 (VUSes) のネットワーク分析と,EGFR変異体でファーストラインオシメルチニブで治療された患者の予後におけるその役割
1Department of Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
ESMO open
|August 30, 2025
まとめ
非小細胞性肺がんでは,特にオシメルチニブで治療された患者でEGFR変異と併発すると,不確実な重要性を持つニューレグルリン1 (NRG1) 変異は一般的です.
科学分野:
- 腫瘍学
- ゲノミクス
- 分子生物学
背景:
- ニューレグリン1 (NRG1) 融合は,がんにおける潜在的な治療標的である.
- NRG1変異の現実世界での流行と予後効果に関するデータは限られている.
研究 の 目的:
- 進行性非小細胞肺がん (NSCLC) のNRG1変異の流行病学的分布と予後値を調査する.
- オシメルチニブを投与されたEGFR変異性NSCLC患者の治療結果に対するNRG1変異の影響を評価する.
主な方法:
- 878人のNSCLC患者からの包括的なゲノム分析データ.
- オシメルチニブで治療されたEGFR変異患者のコホートにおける多変量分析
主要な成果:
- NRG1変異の重要性不明 (VUSes) は患者の8. 0%で確認され,しばしば他の腫瘍性変異 (EGFR,HER2,KRAS) と併発した.
- オシメルチニブで治療されたEGFR変異性NSCLC患者の同期NRG1変異は,相変わらず,進行性生存期 (PFS) と全生存期 (OS) が著しく短縮された.
結論:
- NRG1 VUSはしばしば不良の予後と関連しており,NSCLCにおける他の腫瘍遺伝子の変異と併発する.
- オシメルチニブで治療されたEGFR変異性NSCLC患者におけるNRG1変異は,独立した不良予後因子であり,さらなる調査が必要である.
関連する概念動画
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...